How interferon-gamma keeps autoimmune diseases in check.

Area of Science:

• Immunology
• Autoimmune Diseases
• Cytokine Signaling

Background:

• Interferon-gamma (IFN-gamma) is traditionally considered a proinflammatory cytokine.
• It is often associated with Th1-dominated autoimmune processes.
• Recent evidence suggests IFN-gamma may counteract inflammation in autoimmune diseases.

Purpose of the Study:

• To review evidence for IFN-gamma's anti-inflammatory effects.
• To question the classic proinflammatory role of IFN-gamma.
• To re-evaluate the Th1-Th2 paradigm in autoimmune disease regulation.

Main Methods:

• Review of existing literature on IFN-gamma.
• Focus on experimental models, specifically collagen-induced arthritis (CIA).
• Analysis of pathways through which IFN-gamma modulates inflammation.

Main Results:

• IFN-gamma exhibits anti-inflammatory effects in Th1-associated autoimmune diseases.
• Evidence challenges the solely proinflammatory role of IFN-gamma.
• The Th1-Th2 paradigm may be insufficient for explaining autoimmune regulation.

Conclusions:

• Endogenous IFN-gamma production has bidirectional immunoregulatory consequences.
• IFN-gamma often results in moderation of pathology during autoimmune diseases.
• The role of IFN-gamma in autoimmune diseases is more complex than previously thought.